This study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management approaches.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
140
Massachusetts General Hospital
Charlestown, Massachusetts, United States
RECRUITINGM1 resting state functional connectivity
Changes in brain resting-state connectivity between the primary motor cortex (M1) and other brain regions pre- and post-treatments, analyzed using the CONN Toolbox (https://web.conn-toolbox.org/)
Time frame: Baseline, post-treatment (12 weeks)
Change on Cerebral blood flow
Cerebral blood flow will be measured using arterial spin labeling (ASL)
Time frame: Baseline, post-treatment (12 weeks)
Change on M1 corticospinal excitability and cortico-cortical excitability
M1 corticospinal excitability will be measured using motor threshold, motor evoked potential, short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF).
Time frame: Baseline, post-treatment (12 weeks)
Change on brain gray matter volume
Voxel-based morphometry (VBM) analysis will be performed to investigate gray matter volume changes.
Time frame: Baseline, post-treatment (12 weeks)
Change on Knee Injury and Osteoarthritis Outcome Score (KOOS)
The KOOS is a 35-item self-administered survey of pain and function in knee OA patients.
Time frame: Baseline, post-treatment (12 weeks), follow-up (24 weeks)
Change on Patient-Reported Outcomes Measurement Information System (PROMIS)-29
We will use PROMIS-29 to assess pain, function, depression, anxiety, and sleep in the past 7 days.
Time frame: Baseline, post-treatment (12 weeks), follow-up (24 weeks)
change on Beck's Depression Inventory (BDI-II)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
exercise including stretching and other activities.
BDI-II is designed for individuals aged 13 and over and is composed of items relating to symptoms of depression.
Time frame: Baseline, post-treatment (12 weeks), follow-up (24 weeks)
Change on Pain Catastrophizing Scale (PCS)
PCS is a 15-item questionnaire used to characterize an individual's tendency to magnify the threat value of a pain experience and to feel helpless in the presence of pain.
Time frame: Baseline, post-treatment (12 weeks), follow-up (24 weeks)
Change on Quantitative Sensory Testing (QST)
Pressure pain thresholds will be assessed 3 times using a Somedic digital pressure algometer. Contact heat stimuli will be delivered using a PATHWAY CHEPS (Contact Heat-Evoked Potential Stimulator, Medoc Advanced Medical Systems).
Time frame: Baseline, post-treatment (12 weeks), follow-up (24 weeks)
Change on 6-Minute Walk Test
The 6-Minute Walk Test is a self-paced endurance test that assesses walking ability and endurance and includes standardized encouragement that increase tolerability in elders and those with physical impairment.
Time frame: Baseline, post-treatment (12 weeks), follow-up (24 weeks)